Trends in target novelty in oncology R&D
Analyst opinion article published in the journal Nature Reviews Drug Discovery
Oncology CI and market insights
I am a freelancer/contractor specializing in oncology. I can aid the drug development process through competitive intelligence work, forecasting, and other market assessments.
- Sakis Paliouras, PhD
I can support a variety of oncology needs
I have years of experience in producing syndicated market reports in various cancer types, analyzing clinical data, and participating in consulting deliverables.
-
Initial Consultation
Through an introductory call I will seek to understand your needs and estimate the scope of the project.
-
Speed is of the Essence
If there is a good fit, we can proceed to the proposal stage and we will agree on a timeline we are both comfortable with.
-
Responsiveness
You can rely on me to be responsive and accesible when we work together.
Project Types
- Competitive Intelligence
- Forecasting/Market Sizing
- AI Automation
- Unmet Need Analysis
- BD Prioritization
- Clinical Data Evaluation
- Data Analysis & Dashboards
- Automation of Data Analysis
- Database Coding
- Other Secondary Research
What clients say
“Sakis at Celeritas Insights has been an excellent collaborator, bringing a rare mix of oncology knowledge and AI innovation. I’ve found him reliable, innovative, and a trusted problem solver throughout our work together.”
“For the market assessment and forecast of our clinical stage oncology asset, Celeritas Insights has been very professional every step of the way in the process. From customizing product profile and questionnaires to KOLs, generating market landscape and forecast, to helping our company to make informed decisions, the team demonstrated its valued position in the industry.”
My education and career so far
10+ years of oncology experience
-
2009 - 2014
Democritus University of Thrace, Greece
BSc in Molecular Biology and Genetics with a focus on cell biology
-
2015 - 2019
Cancer Research UK Manchester Institute, University of Manchester
PhD in Cancer Medicine, focusing on EML4-ALK driven non-small lung cancer and mechanisms of resistance to targeted therapies
-
2019 - 2024
GlobalData Healthcare
I worked as an Associate Director in GlobalData's Oncology & Hematology team where I produced and managed a portfolio of oncology syndicated reports. I have worked in over 20 oncology indications, with examples including Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Neuroendocrine Tumors, T-Cell Lymphomas, Head and Neck Cancer, Breast Cancer, Glioblastoma, Melanoma, Chronic Myeloid Leukemia, Non-Small Cell Lung Cancer
-
2024+
Celeritas Insights
I work as an independent oncology consultant, helping biotech and pharma companies with competitive intelligence, BD prioritization, forecasting and AI automation projects.
Publication List
The most successful oncology drug portfolios of the past decade
Analyst opinion article published in the journal Nature Reviews Drug Discovery
Vulnerability of drug-resistant EML4-ALK rearranged lung cancer to transcriptional inhibition
Originial research article published in the journal EMBO Molecular Medicine
Get in touch
Have a question or a project in mind? Send me a message and I'll get back to you as soon as I can.
Newsletter
Occasional thoughts on oncology R&D: important trial results, emerging mechanisms of action, and anything that can change market dynamics. Sent when I have something to say.